Reliability and Validation of 3-D Electromagnetic Tracking During Pelvic Floor Muscle (PFM) Activation - a Pilot Study
Recruitment status was Not yet recruiting
Now a days the ultrasound is seen as a valid and reliable measurement tool to test the Pelvic Floor Muscle (PFM) movement (Sherburn, Murphy, Carroll, Allen, & Galea, 2005). The hypothesis is that the electromagnetic tracking system, TrakSTARTM, can measure the PFM movement in an equal or even more precise way. The TrakSTARTM will have the advantage to be used in measuring functional movements. In this Master thesis the hypothesis is to show a good reliability by trampoline jumping (physical activity).
Pelvic Floor Dyssynergia
|Official Title:||Reliability and Validation of 3-D Electromagnetic Tracking During Pelvic Floor Muscle (PFM) Activation - a Pilot Study|
- the way in x-y coordinates for the pelvic floor mouvement measured by the ultrasonography and TrakSTAR [ Time Frame: one year ] [ Designated as safety issue: No ]the mouvement of the pelvic floor is measured similtanous by the ultrasound and the TrakSTAR
- EMG [ Time Frame: one year ] [ Designated as safety issue: No ]EMG will measure the contraction of the plevic floor
|Study Start Date:||August 2012|
|Estimated Study Completion Date:||May 2013|
|Estimated Primary Completion Date:||February 2013 (Final data collection date for primary outcome measure)|
|20 healthy women|
There will be two measurements. One measurement of MVIC and quick flicks will be done in a standing and supine position with 3 repetitions. The TrakSTARTM, Ultrasound, surface EMG and Accelerometer will measure the PFM movements and activation simultaneously. The Ultrasound is measured from one tester (to guaranty a high intratester reliability) (Sherburn et al., 2005).
TrakSTARTM, surface EMG and Accelerometer will measure 3 Trampoline jumps. The measurements will be done once during one hour. The women will insert the vaginal probe by themselves and stay dressed during the measurement procedure. The measurements will be done in a standardized way. All the arrangements are made to ensure the hygiene requirements.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01590927
|Contact: Helene Moser, Msc in email@example.com|
|Inselspital||Not yet recruiting|
|Bern, Switzerland, 3010|
|Contact: Helene Moser, MSc in study 0041787752118 firstname.lastname@example.org|
|Study Chair:||Lorenz Radlinger, PhD||Berner Fachhochschule Gesundheit, Bern, Switzerland|